MBP and amyotrophic lateral sclerosis: Our data suggests that certain SVAs (SVA_90 and SVA_5) act to downregulate MBP gene expressions; therefore, SVAs could play a role in this mechanism, leading to the reduction in MBP protein levels observed in the ALS patients compared to the controls.